Both trial vials were independently muscle tested using accepted AK techniques.
Isokinetic muscle strength testing using hand-held dynamometry has been shown to be a more sensitive and objective method of strength testing compared to MMT [25, 27 30].
There are inherent limitations with volitional muscle strength testing using HGD and MMT.
Manual muscle strength testing using the Medical Research Council (MRC) sum score was pro-posed as a diagnostic criterion for ICUAW [ 5].
The aims of this study were: to determine the inter-rater reliability and agreement of manual muscle strength testing using both isometric and through-range techniques using the Medical Research Council sum score and a new four-point scale, and to examine the validity of HGD and determine a cutoff score for the diagnosis of ICU-AW for the new four-point scale.
For these anti-HMGCR-positive patients, the following parameters were recorded from their medical reports: age, sex, past medical history, statin exposure, characteristics of myopathy including clinical manifestation and muscular deficit evaluation by muscle manual testing using the Medical Research Council scale on five points, and creatine kinase (CK) level at the date of the anti-HMGCR assay.
Manual muscle testing (MMT) using the Medical Research Council MRCC) scale [14] was yearly performed, yielding upper limb (average value of 2×5 muscles), lower limb (2×4 muscles) and global (2×9 muscles) scores reported at ages 8 and 10.
Manual muscle testing (MMT) using the six-point Medical Research Council sum score (MRC-SS) is currently the recommended method for diagnosing ICU-AW [ 4- 6].
Various degrees of strength improvement by manual muscle testing (MMT) using the Medical Research Council (MRC) 1 5 scale (2 ) were seen in the 18 of 27 patients with poliomyelitis-like syndrome at 1 year.
A suspected case of WNV-associated weakness was defined as muscle weakness in a person of at least 1-point decrement on manual muscle testing by using the Medical Research Council (London, UK) 1 5 scale, respiratory failure requiring intubation that developed <48 hours after presentation, or both.
